Hypera Buys Boehringer’s Buscopan in Brazil

Hypera has agreed to pay BRL1.3bn to acquire the rights in Brazil to Buscopan and Buscofem from Boehringer Ingelheim. 

BrazilianPill_1200x675

More from Deals

More from Business